Leicester Research Archive >
College of Medicine, Biological Sciences and Psychology >
Cancer Studies and Molecular Medicine, Department of >
Published Articles, Dept. of Cancer Studies and Molecular Medicine >
Please use this identifier to cite or link to this item:
|Title: ||Analysis of urinary8-oxo-7,8-dihydro-purine-2’-deoxyribonucleosides by LC-MS/MS and improved ELISA|
|Authors: ||Evans, Mark D.|
Farmer, Peter B.
Cooke, Marcus S.
|Issue Date: ||Oct-2008|
|Publisher: ||Taylor and Francis|
|Citation: ||Free Radical Research, 2008, 42 (10), pp. 831-840|
|Abstract: ||Non-invasive monitoring of oxidative stress is highly desirable. Urinary 7,8-dihydro-
8-oxo-2’-deoxyguanosine (8-oxodG) is a biologically relevant and convenient analytical target. However, immunoassays can over-estimate levels of urinary 8-oxodG. Measurement of more than one DNA oxidation product in urine would be advantageous in terms of mechanistic information. Urines samples were analysed for 8-oxodG by solid-phase extraction/LC-MS/MS and ELISA. The solid-phase extraction/LC-MS/MS assay was also applied to the analysis of urinary 7,8-dihydro-8-oxo-2’-deoxyadenosine (8-oxodA). Concurring with previous reports, urinary 8-
oxodG measured by ELISA was significantly higher than levels measured by LCMS/MS. However, apparent improvement in the specificity of the commercially available Japanese Institute for the Control of Ageing (JaICA) ELISA brought mean LC-MS/MS and ELISA measurements of urinary 8-oxodG into agreement. Urinary 8-oxodA was undetectable in all urines, despite efficient recovery by solid phase extraction. Exploitation of the advantages of ELISA may be enhanced by a simple modification to the assay procedure, although chromatographic techniques still remain the ‘gold standard’ techniques for analysis of urinary 8-oxodG. Urinary 8-oxodA is either not present or below the limit of detection of our instrumentation.|
|Description: ||This is the author's final draft of the paper published as Free Radical Research, 2008, 42 (10), pp. 831-840. The final published version is available at http://informahealthcare.com/doi/abs/10.1080/10715760802506323, Doi: 10.1080/10715760802506323.|
|Appears in Collections:||Published Articles, Dept. of Cancer Studies and Molecular Medicine|
Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.